Ke Cao (K Cao)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Third Xiangya Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Third Xiangya Hospital

China

PI :: Department of Oncology

Publications

Panpan Tai, Xinyu Chen, Guihua Jia, Guanjun Chen, Lian Gong, Yaxin Cheng, Zhuan Li, Heng Wang, Aiyan Chen, Ganghua Zhang, Yuxing Zhu, Mengqing Xiao, Zhanwang Wang, Yunqing Liu, Dongyong Shan, Dong He, Moying Li, Tianzuo Zhan, Abbas Khan, Xiaohui Li, Xiangxiang Zeng, Chaopeng Li, Dongsheng Ouyang, Kelong Ai, Xuan Chen, Dongbo Liu, Zhonghua Liu, Dongqing Wei, Ke Cao
WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis. Journal of translational medicine 21 (1) (2023)
Haotian Chen, Yao Zhang, Xingyu Chen, Runshi Xu, Yuxing Zhu, Dong He, YaXin Cheng, Zhanwang Wang, Xiang Qing, Ke Cao
Hypoxia is correlated with the tumor immune microenvironment: Potential application of immunotherapy in bladder cancer. Cancer medicine (2023)
Panpan Tai, Zhanwang Wang, Xinyu Chen, Aiyan Chen, Lian Gong, Yaxin Cheng, Ke Cao
Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers. Cancer medicine (2022)
Yi Jin, Zhanwang Wang, Dong He, Yuxing Zhu, Xingyu Chen, Ke Cao
Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma. Cancer medicine 10 (23) (2021)
Yan Liu, Dong He, Mengqing Xiao, Yuxing Zhu, Jianda Zhou, Ke Cao
Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma. Cell death & disease 12 (3) (2021)
Xingyu Chen, Runshi Xu, Dong He, Yao Zhang, Haotian Chen, Yuxing Zhu, YaXin Cheng, Rui Liu, Rongrong Zhu, Lian Gong, Mengqing Xiao, Zhanwang Wang, Liping Deng, Ke Cao
CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer. Oncogene 40 (43) (2021)
Xingyu Chen, Haotian Chen, Honghui Yao, Kai Zhao, Yao Zhang, Dong He, Yuxing Zhu, YaXin Cheng, Rui Liu, Runshi Xu, Ke Cao
Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer. Oncogene 40 (45) (2021)
Xiaoming Liu, Jianye Liu, Wen Xiao, Qinghai Zeng, Hao Bo, Yuxing Zhu, Lian Gong, Dong He, Xiaowei Xing, Ruhong Li, Ming Zhou, Wei Xiong, Yanhong Zhou, Jianda Zhou, Xiaohui Li, Fei Guo, Canxia Xu, Xiong Chen, Xiaoyan Wang, Fen Wang, Qiang Wang, Ke Cao
SIRT1 Regulates N6 -Methyladenosine RNA Modification in Hepatocarcinogenesis by Inducing RANBP2-Dependent FTO SUMOylation. Hepatology (Baltimore, Md.) 72 (6) (2020)
Lian Gong, Yi Hu, Dong He, Yuxing Zhu, Liang Xiang, Mengqing Xiao, Ying Bao, Xiaoming Liu, Qinghai Zeng, Jianye Liu, Ming Zhou, Yanhong Zhou, Yaxin Cheng, Yeyu Zhang, Liping Deng, Rongrong Zhu, Hua Lan, Ke Cao
Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation. Cancer cell international 20 (2020)
Yuxing Zhu, Jingjing Li, Hao Bo, Dong He, Mengqing Xiao, Liang Xiang, Lian Gong, Yi Hu, Yeyu Zhang, Yaxin Cheng, Liping Deng, Rongrong Zhu, Yanni Ma, Ke Cao
LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression. Oncogene 39 (38) (2020)
Zhaoxin Hu, Hao Zhang, Bin Yi, Shi-Kun Yang, Jun Liu, Jing Hu, Jianwen Wang, Ke Cao, Wei Zhang
VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell death & disease 11 (1) (2020)
Yuxing Zhu, Dong He, Hao Bo, Ze-Xian Liu, Mengqing Xiao, Liang Xiang, Jianda Zhou, Yan Liu, Xiaoming Liu, Lian Gong, Yanni Ma, Yanhong Zhou, Ming Zhou, Wei Xiong, Fei Yang, Xiao-Wei Xing, Ruhong Li, Wei Li, Ke Cao
The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway. Oncogene 38 (32) (2019)
Jianye Liu, Yi Zhang, Qinghai Zeng, Hongliang Zeng, Xiaoming Liu, Pei Wu, Hongyi Xie, Leye He, Zhi Long, Xiaoyong Lu, Mengqing Xiao, Yuxing Zhu, Hao Bo, Ke Cao
Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes. Science advances 5 (9) (2019)
J Y Liu, Q H Zeng, P G Cao, D Xie, F Yang, L Y He, Y B Dai, J J Li, X M Liu, H L Zeng, X J Fan, L Liu, Y X Zhu, L Gong, Y Cheng, J D Zhou, J Hu, H Bo, Z Z Xu, Ke Cao
SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival. Oncogene 37 (29) (2018)

Ke Cao.css-eqlu8i{font-size:small;padding-left:4px;} (K Cao)

Publication Activity (10 Years)

Top Topics

Top Venues

Ke Cao (K Cao)